Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters.Denali Therapeutics, a biopharmaceutical company developing…
Denali Therapeutics’ $316 Million Public Offering
![](https://globallegalchronicle.com/wp-content/uploads/2022/10/denali-therapeutics-316-million-public-offering_635b78970cefc.jpeg)